First Personal Financial Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $90.9K | Hold |
624
| – | – | 0.02% | 169 |
|
|
2024
Q2 | $85.7K | Hold |
624
| – | – | 0.02% | 167 |
|
|
2024
Q1 | $85.6K | Hold |
624
| – | – | 0.02% | 163 |
|
|
2023
Q4 | $84.8K | Hold |
624
| – | – | 0.02% | 169 |
|
|
2023
Q3 | $76.3K | Hold |
624
| – | – | 0.02% | 173 |
|
|
2023
Q2 | $79.2K | Hold |
624
| – | – | 0.02% | 173 |
|
|
2023
Q1 | $80.6K | Hold |
624
| – | – | 0.02% | 168 |
|
|
2022
Q4 | $81.9K | Sell |
624
-45
| -7% | -$5.91K | 0.02% | 170 |
|
|
2022
Q3 | $78K | Buy |
669
+21
| +3% | +$2.45K | 0.02% | 162 |
|
|
2022
Q2 | $76K | Hold |
648
| – | – | 0.02% | 152 |
|
|
2022
Q1 | $84K | Sell |
648
-71
| -10% | -$9.2K | 0.02% | 158 |
|
|
2021
Q4 | $110K | Hold |
719
| – | – | 0.02% | 145 |
|
|
2021
Q3 | $116K | Hold |
719
| – | – | 0.03% | 143 |
|
|
2021
Q2 | $118K | Hold |
719
| – | – | 0.03% | 141 |
|
|
2021
Q1 | $108K | Hold |
719
| – | – | 0.03% | 142 |
|
|
2020
Q4 | $109K | Hold |
719
| – | – | 0.03% | 140 |
|
|
2020
Q3 | $97K | Hold |
719
| – | – | 0.03% | 143 |
|
|
2020
Q2 | $98K | Hold |
719
| – | – | 0.03% | 143 |
|
|
2020
Q1 | $77K | Sell |
719
-25
| -3% | -$2.68K | 0.03% | 155 |
|
|
2019
Q4 | $90K | Sell |
744
-645
| -46% | -$78K | 0.03% | 159 |
|
|
2019
Q3 | $138K | Hold |
1,389
| – | – | 0.04% | 154 |
|
|
2019
Q2 | $152K | Hold |
1,389
| – | – | 0.04% | 181 |
|
|
2019
Q1 | $155K | Sell |
1,389
-195
| -12% | -$21.8K | 0.05% | 172 |
|
|
2018
Q4 | $153K | Hold |
1,584
| – | – | 0.05% | 168 |
|
|
2018
Q3 | $193K | Hold |
1,584
| – | – | 0.06% | 165 |
|
|
2018
Q2 | $174K | Hold |
1,584
| – | – | 0.06% | 170 |
|
|
2018
Q1 | $169K | Hold |
1,584
| – | – | 0.04% | 235 |
|
|
2017
Q4 | $169K | Sell |
1,584
-885
| -36% | -$94.4K | 0.03% | 259 |
|
|
2017
Q3 | $275K | Buy |
2,469
+285
| +13% | +$31.7K | 0.06% | 190 |
|
|
2017
Q2 | $226K | Buy |
2,184
+357
| +20% | +$36.9K | 0.05% | 207 |
|
|
2017
Q1 | $179K | Sell |
1,827
-180
| -9% | -$17.6K | 0.04% | 210 |
|
|
2016
Q4 | $178K | Sell |
2,007
-165
| -8% | -$14.6K | 0.05% | 202 |
|
|
2016
Q3 | $210K | Buy |
2,172
+63
| +3% | +$6.09K | 0.06% | 155 |
|
|
2016
Q2 | $181K | Sell |
2,109
-1,512
| -42% | -$130K | 0.06% | 155 |
|
|
2016
Q1 | $315K | Sell |
3,621
-528
| -13% | -$45.9K | 0.16% | 105 |
|
|
2015
Q4 | $468K | Sell |
4,149
-444
| -10% | -$50.1K | 0.26% | 87 |
|
|
2015
Q3 | $465K | Buy |
4,593
+150
| +3% | +$15.2K | 0.28% | 83 |
|
|
2015
Q2 | $547K | Sell |
4,443
-720
| -14% | -$88.6K | 0.33% | 80 |
|
|
2015
Q1 | $592K | Sell |
5,163
-1,371
| -21% | -$157K | 0.36% | 79 |
|
|
2014
Q4 | $660K | Buy |
+6,534
| New | +$660K | 0.39% | 73 |
|